Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00371852
Other study ID # LACTO_L_01811
Secondary ID
Status Completed
Phase Phase 3
First received August 31, 2006
Last updated May 15, 2008
Start date May 2006

Study information

Verified date May 2008
Source Sanofi
Contact n/a
Is FDA regulated No
Health authority Brazil: National Health Surveillance Agency
Study type Interventional

Clinical Trial Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd wipes.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

- Phototypes: I, II, III and IV;

- Integral skin test in the region;

Exclusion Criteria:

- Lactation or gestation

- Use of Anti-inflammatory and/or immune-suppression drugs

- Personnel history of atopy;

- History of sensibilization or irritation for topic products;

- Active cutaneous disease;

- Use of new drugs and/or cosmetics during the study

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
lactoserum


Locations

Country Name City State
Brazil Sanofi-aventis São Paulo

Sponsors (1)

Lead Sponsor Collaborator
Sanofi

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Score evaluation of the cutaneous reaction, preconized by International Contact Dermatitis Research Group (ICDRG)
See also
  Status Clinical Trial Phase
Completed NCT02342860 - The Impact of Improved WASH in Schools on Absence, Diarrhea and Helminth Infection in Lao PDR N/A
Completed NCT00783939 - Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety. Phase 3
Completed NCT00783640 - Dermacyd Femina (Lactic Acid) Pocket BR - Photo Evaluation Phase 3
Completed NCT00784121 - Dermacyd Breeze (Lactic Acid) Pocket BR - Compatibility Phase 3
Completed NCT00783861 - Dermacyd Femina (Lactic Acid) Pocket BR - Compatibility Phase 3
Completed NCT00784069 - Dermacyd Breeze (Lactic Acid) Pocket BR - Photo Evaluation Phase 3
Completed NCT00794612 - Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability. Phase 3
Completed NCT00793026 - Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability Phase 3
Completed NCT04382690 - Behavioral Determinants That May Influence People's Hand-hygiene and Environment Disinfecting
Completed NCT00761800 - Dermacyd Teen Care Tangerina Mix - Compatibility Phase 3
Completed NCT00497783 - Acceptability Lactoserum (Dermacyd Delicata - New Fragrance) Phase 4
Completed NCT00497692 - Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance) Phase 4
Completed NCT00380991 - Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - Hygiene Phase 3
Completed NCT03032887 - Reducing Visitors- and Personnel-associated Infection Risk on Perinatal Care Station N/A
Completed NCT00881270 - Dermacyd Infantile - Acceptability. Phase 4
Completed NCT00679562 - Lactacyd Radiance (Lactic Acid) Prophetic Patch Test Phase 2
Completed NCT00933075 - Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation. Phase 3
Completed NCT00933504 - Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on Floral Phase 3
Completed NCT00933712 - Dermacyd Silver Floral (Lactic Acid) - Compatibility. Phase 3
Completed NCT00932945 - Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal Phase 3